113 related articles for article (PubMed ID: 7349339)
1. Pharmacokinetics of theophylline in swine: a potential model for human drug bioavailability studies.
Koritz GD; Bourne DW; Hunt JP; Prasad VI; Bevill RF; Gautam SR
J Vet Pharmacol Ther; 1981 Sep; 4(3):233-9. PubMed ID: 7349339
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics and bioavailability of theophylline in horses.
Errecalde JO; Button C; Baggot JD; Mulders MS
J Vet Pharmacol Ther; 1984 Dec; 7(4):255-63. PubMed ID: 6512916
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetic studies of theophylline in dogs.
McKiernan BC; Neff-Davis CA; Koritz GD; Davis LE; Pheris DR
J Vet Pharmacol Ther; 1981 Jun; 4(2):103-10. PubMed ID: 7349323
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of theophylline in beagle dogs and asthmatic patients after multiple oral doses of sustained-release theophylline tablet formulation.
Nosaka H; Takagi K; Hasegawa T; Ogura Y; Mizukami Y; Satake T
Int J Clin Pharmacol Ther Toxicol; 1986 Oct; 24(10):528-35. PubMed ID: 3781672
[TBL] [Abstract][Full Text] [Related]
5. The effect of food on the absorption of controlled-release theophylline in mini-swine.
Shiu GK; Sager AO; Velagapudi RB; Prasad VK; Skelly JP
Pharm Res; 1988 Jan; 5(1):48-52. PubMed ID: 3244609
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetic studies of theophylline in horses.
Ingvast-Larsson C; Paalzow G; Paalzow L; Ottosson T; Lindholm A; Appelgren LE
J Vet Pharmacol Ther; 1985 Mar; 8(1):76-81. PubMed ID: 3989903
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of the bioavailability and pharmacokinetics of two extended-release theophylline formulations in dogs.
Bach JE; Kukanich B; Papich MG; McKiernan BC
J Am Vet Med Assoc; 2004 Apr; 224(7):1113-9. PubMed ID: 15074856
[TBL] [Abstract][Full Text] [Related]
8. [Human pharmacokinetics of theophylline and etofylline from different formulations of a cardiotonic (author's transl)].
Erking W; Lücker PW; Niebch G; Thiemer K; Wetzelsberger K
Arzneimittelforschung; 1981; 31(2):371-9. PubMed ID: 7194656
[TBL] [Abstract][Full Text] [Related]
9. Bioavailability and pharmacokinetics of theophylline in plain uncoated and sustained-release dosage forms in relation to smoking habit. I. Single dose study.
Horai Y; Ishizaki T; Sasaki T; Chiba K; Suganuma T; Echizen H; Ohnishi A
Eur J Clin Pharmacol; 1983; 24(1):79-87. PubMed ID: 6832206
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetic studies of theophylline in cats.
McKiernan BC; Koritz GD; Davis LE; Neff-Davis CA; Pheris DR
J Vet Pharmacol Ther; 1983 Jun; 6(2):99-104. PubMed ID: 6887346
[TBL] [Abstract][Full Text] [Related]
11. The pharmacokinetics of dihydroxypropyltheophylline: a basis for rational therapy.
Simons FE; Simons KJ; Bierman CW
J Allergy Clin Immunol; 1975 Nov; 56(5):347-55. PubMed ID: 1181352
[TBL] [Abstract][Full Text] [Related]
12. Bioavailability and pharmacokinetics in man of orally administered theophylline.
Nielsen-Kudsk F; Magnussen I; Jensen TS; Naeser K
Acta Pharmacol Toxicol (Copenh); 1980 Mar; 46(3):205-12. PubMed ID: 7361576
[TBL] [Abstract][Full Text] [Related]
13. Study of bioavailability and pharmacokinetics of theophylline following administration of two sustained release dosage forms as assessed by salivary data: Part II.
Ohmori N; Inotsume N; Matsukura M; Higashi A; Iwaoku R; Tobino Y; Nakano M; Matsuda I
Int J Clin Pharmacol Ther Toxicol; 1986 Apr; 24(4):196-201. PubMed ID: 3710632
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetic properties of theophylline given intravenously and orally to ruminating calves.
Langston VC; Koritz GD; Davis LE; Neff-Davis C
Am J Vet Res; 1989 Apr; 50(4):493-7. PubMed ID: 2712416
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics of etofylline after intravenous and oral administration to humans.
Zuidema J; Verhoeven J; Merkus FW
Int J Clin Pharmacol Ther Toxicol; 1981 Jul; 19(7):310-3. PubMed ID: 7263108
[TBL] [Abstract][Full Text] [Related]
16. Theophylline absorption and disposition in rabbits: oral, intravenous, and concentration-dependent kinetic studies.
El-Yazigi A; Sawchuk RJ
J Pharm Sci; 1981 Apr; 70(4):452-6. PubMed ID: 7229966
[TBL] [Abstract][Full Text] [Related]
17. The pharmacokinetics of a slow-release theophylline preparation in horses after intravenous and oral administration.
Errecalde JO; Landoni MF
Vet Res Commun; 1992; 16(2):131-8. PubMed ID: 1496815
[TBL] [Abstract][Full Text] [Related]
18. Disposition and clinical pharmacokinetics of microcrystalline theophylline.
Jonkman JH; Berg WC; Schoenmaker R; de Zeeuw RA; Greving JE; Orie NG
Eur J Clin Pharmacol; 1980 May; 17(5):379-84. PubMed ID: 7418716
[TBL] [Abstract][Full Text] [Related]
19. Oral bioavailability of theophylline from hydroalcoholic and alcohol-free preparations.
Sligo JH; Charles BG; Ravenscroft PJ
Med J Aust; 1981 Oct; 2(8):410-1. PubMed ID: 7321973
[TBL] [Abstract][Full Text] [Related]
20. The beagle dog as an animal model for a bioavailability study of controlled-release theophylline under the influence of food.
Shiu GK; LeMarchand A; Sager AO; Velagapudi RB; Skelly JP
Pharm Res; 1989 Dec; 6(12):1039-42. PubMed ID: 2622858
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
